Non-practising entities are controversial, but political winds in the US are shifting and inventors, investors, and operating companies of all stripes should take note, writes Manny Caixeiro of ...

Patent prosecution is a significant driver of IP costs in the US and abroad. With rising fees and other industry cost ...

The executive chair of Beck Greener enabled a smaller firm to swerve private equity and join its stable — a move that boosts ...

A high number of filings from China has driven patent applications up by nearly a third at Ireland’s intellectual property ...

Bilingual litigator brings experience of handling IP disputes across multiple industries, from medical devices and ...

9 July 2025 California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring ...

18 June 2024 Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & ...

Insulet and Masimo are among the parties that feature in this year’s one-of-a-kind rankings, courtesy of sister magazine WIPR ...

8 October 2024 A UK court upholds the patent for Astellas Pharma's life-extending prostate cancer treatment | Judgment ...

13 June 2025 Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest ...

‘One of the nation’s most accomplished ITC litigators” brought in to lead global practice at BigLaw firm. Already registered?

Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | BMS’s Indian patent covering the monoclonal antibody expires in May 2026.